NCT02580370View on ClinicalTrials.gov

Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Lateral Canthal Lines

PHASE3CompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

August 31, 2016

Conditions
Skin Aging
Interventions
BIOLOGICAL

Botulinum toxin type A

Topical botulinum toxin type A

BIOLOGICAL

Placebo comparator

Topical placebo comparator

Trial Locations (1)

33146

Coral Gables

All Listed Sponsors
lead

Revance Therapeutics, Inc.

INDUSTRY

NCT02580370 - Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Lateral Canthal Lines | Biotech Hunter | Biotech Hunter